O	0	10	Preventing
B-condition	11	17	seroma
I-condition	18	27	formation
O	28	33	after
O	34	42	axillary
O	43	53	dissection
O	54	57	for
O	58	64	breast
O	65	71	cancer
O	71	72	:
O	73	74	a
O	75	85	randomized
O	86	94	clinical
O	95	100	trial
O	100	101	.

O	102	108	Seroma
O	109	118	formation
O	119	124	after
O	125	133	axillary
O	134	144	dissection
O	145	152	remains
O	153	156	the
O	157	161	most
O	162	168	common
O	169	174	early
O	175	181	sequel
O	182	184	to
O	185	191	breast
O	192	198	cancer
O	199	206	surgery
O	206	207	.

O	208	217	Different
O	218	226	surgical
O	227	237	approaches
O	238	242	have
O	243	247	been
O	248	257	performed
O	258	260	to
O	261	267	reduce
O	268	274	seroma
O	275	285	collection
O	285	286	.

O	287	296	Therefore
O	296	297	,
O	298	300	we
O	301	306	aimed
O	307	309	to
O	310	316	assess
O	317	320	the
O	321	328	outcome
O	329	331	of
O	332	340	patients
O	341	349	operated
O	350	352	on
O	353	358	using
O	359	361	an
O	362	372	ultrasound
O	373	380	scalpel
O	381	390	according
O	391	393	to
O	394	395	a
O	396	408	standardized
O	409	418	operative
O	419	428	technique
O	429	435	before
O	436	445	accepting
O	446	448	it
O	449	451	as
O	452	453	a
O	454	461	routine
O	462	471	procedure
O	471	472	.

O	473	474	A
O	475	485	randomized
O	486	496	controlled
O	497	502	trial
O	503	506	was
O	507	515	designed
O	516	518	to
O	519	526	compare
O	527	530	the
O	531	538	outcome
O	539	541	of
B-eligibility	542	550	patients
I-eligibility	551	561	undergoing
I-eligibility	562	568	breast
I-eligibility	569	576	surgery
I-eligibility	577	580	and
I-eligibility	581	589	axillary
I-eligibility	590	600	dissection
O	601	606	using
O	607	613	either
B-intervention	614	622	standard
I-intervention	623	630	scalpel
I-intervention	631	637	blades
I-intervention	637	638	,
I-intervention	639	647	scissors
I-intervention	647	648	,
I-intervention	649	658	ligations
I-intervention	658	659	,
I-intervention	660	663	and
I-intervention	664	678	electrocautery
O	679	681	or
O	682	685	the
B-control	686	696	ultrasound
I-control	697	704	scalpel
I-control	705	709	only
O	709	710	.

O	711	715	Each
O	716	719	arm
O	720	722	of
O	723	726	the
O	727	732	trial
O	733	742	consisted
O	743	745	of
B-intervention-participants	746	748	30
O	749	757	patients
O	757	758	.

O	759	760	A
O	761	774	statistically
O	775	786	significant
O	787	794	benefit
O	795	797	in
O	798	803	terms
O	804	806	of
B-outcome	807	815	axillary
I-outcome	816	819	and
I-outcome	820	825	chest
I-outcome	826	830	wall
I-outcome	831	839	drainage
I-outcome	840	846	volume
O	846	847	,
O	848	851	the
B-outcome	852	858	number
I-outcome	859	861	of
I-outcome	862	868	axilla
I-outcome	869	876	seromas
O	876	877	,
B-outcome	878	892	intraoperative
I-outcome	893	901	bleeding
O	901	902	,
O	903	906	and
B-outcome	907	922	hospitalization
I-outcome	923	927	stay
O	928	931	was
O	932	940	recorded
O	941	943	in
O	944	947	the
O	948	956	harmonic
O	957	964	scalpel
O	965	970	group
O	970	971	.

O	972	974	No
O	975	986	significant
O	987	998	differences
O	999	1003	were
O	1004	1009	found
O	1010	1017	between
O	1018	1021	the
O	1022	1023	2
O	1024	1030	groups
O	1031	1033	in
O	1034	1039	terms
O	1040	1042	of
B-outcome	1043	1052	operative
I-outcome	1053	1057	time
O	1057	1058	.

O	1059	1066	Finally
O	1066	1067	,
B-outcome	1068	1070	no
I-outcome	1071	1084	postoperative
I-outcome	1085	1093	hematoma
I-outcome	1093	1094	,
I-outcome	1095	1100	wound
I-outcome	1101	1111	infections
I-outcome	1111	1112	,
I-outcome	1113	1116	and
I-outcome	1117	1122	chest
I-outcome	1123	1127	wall
I-outcome	1128	1134	seroma
O	1135	1139	were
O	1140	1148	observed
O	1148	1149	.

O	1150	1153	The
O	1154	1157	use
O	1158	1160	of
O	1161	1164	the
O	1165	1173	harmonic
O	1174	1181	scalpel
O	1182	1185	was
O	1186	1191	shown
O	1192	1194	to
O	1195	1201	reduce
O	1202	1205	the
B-outcome	1206	1215	magnitude
I-outcome	1216	1218	of
I-outcome	1219	1226	seromas
I-outcome	1227	1229	in
I-outcome	1230	1236	axilla
I-outcome	1237	1240	and
I-outcome	1241	1256	hospitalization
I-outcome	1257	1261	stay
O	1261	1262	.

O	1263	1266	The
O	1267	1275	harmonic
O	1276	1283	scalpel
O	1284	1287	can
O	1288	1290	be
O	1291	1295	used
O	1296	1301	alone
O	1302	1304	in
O	1305	1313	axillary
O	1314	1324	dissection
O	1325	1329	with
O	1330	1331	a
O	1332	1336	safe
O	1337	1340	and
O	1341	1350	effective
O	1351	1361	hemostasis
O	1361	1362	.

O	1363	1366	Our
O	1367	1374	results
O	1375	1379	must
O	1380	1382	be
O	1383	1392	confirmed
O	1393	1395	by
O	1396	1402	larger
O	1403	1409	series
O	1409	1410	.
